Mirabegron

Chemical formula: C₂₁H₂₄N₄O₂S  Molecular mass: 396.506 g/mol  PubChem compound: 9865528

Active ingredient description

Mirabegron is a potent and selective beta3-adrenoceptor agonist. Mirabegron enhances urine storage function by stimulating beta3-adrenoceptors in the bladder.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code Group title Classification
G04BD12 G Genito urinary system and sex hormones → G04 Urologicals → G04B Other urologicals, incl. antispasmodics → G04BD Urinary antispasmodics
Discover more medicines within G04BD12

Product monographs

Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):

Title Information Source Document Type  
BETMIGA Prolonged-release tablet European Medicines Agency (EU) MPI, EU: SmPC

Structural formula

Graphic representation of the active ingredient's molecular structure

External identifiers

CAS Substance: 223673-61-8
DrugBank Drug: DB08893
KEGG Drug: D09535
PubChem Compound: 9865528
RxNorm Ingredient: 1300786
SNOMED-CT Concept: 703803006
Mirabegron (substance)
UNII Identifier: MVR3JL3B2V
MIRABEGRON

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.